Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate

Nephrology Dialysis Transplantation

Volumn 18, Issue 3, 2003, Pages 539-542

  Gæde, Peter ^a   Hansen, Henrik Post ^a   Parving, Hans Henrik ^a   Pedersen, Oluf ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

Acetylsalicylic acid; Albuminuria; Glomerular filtration rate; Randomized trial; Type 2 diabetes mellitus; Urinary albumin excretion rate

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALBYL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HEMOGLOBIN A1C; INDOMETACIN; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PLACEBO; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC ERROR; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DYSPEPSIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; STOMACH ULCER; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADULT; AGED; ALBUMINURIA; ASPIRIN; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0037340014     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.3.539     Document Type: Article

References (14)

1. American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care 2001; 23 [Suppl 1]: S62-S63
2. Mathiesen ER, Hommel E, Olsen UB, Parving H-H. Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy. Diab Med 1988; 5: 145-149
3. Hopper AH, Tindall H, Davies JA. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy. Nephrol Dial Transplant 1989; 4: 140-143
4. Hommel E, Mathiesen ER, Arnold-Larsen S, Edsberg B, Olsen UB, Parving H-H. Effects of indomethacin on kidney function in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1987; 30: 78-81
5. Hansen HP, Gæde PH, Jensen BR, Parving H-H. Lack of impact of low-dose acetylsalicylic acid on kidney function in type 1 diabetic patients with microalbuminuria. Diabetes Care 2000; 23: 1742-1745
6. Bohlen L, de Courten M, Weidmann P. Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 1994; 7: 84s-92s
7. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-581
8. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999; 42: 263-285
9. Benedek IH, Joshi AS, Pieniaszek HJ, King SP, Kornhauser DM. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol 1995; 35: 1181-1186
10. Parving H-H, Rossing N, Nielsen SL, Lassen NA. Increased capillary escape rate of albumin, IgG and IgM after plasma volume expansion. Am J Physiol 1974; 227: 245-250
11. 51Cr]EDTA. Scand J Clin Lab Invest 1976; 36: 247-249
12. Altman DG. Crossover trials. In: Altman DG, ed. Practical Statistics for Medical Research. Chapman & Hall, London, UK: 1997; 467-471
13. Zambraski EJ. The effects of nonsteroidal anti-inflammatory drugs on renal function: experimental studies in animals. Semin Nephrol 1995; 15: 205-213
14. Umeda F, Kuroki T, Nawata H. Prostaglandins and diabetic nephropathy. J Diabetes Complications 1995; 9: 334-336